Charles Robertson
Concepts (527)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 44 | 2024 | 782 | 3.420 |
Why?
| | Gastrointestinal Microbiome | 32 | 2026 | 771 | 2.600 |
Why?
| | RNA, Ribosomal, 16S | 46 | 2026 | 564 | 1.630 |
Why?
| | Bacteria | 32 | 2026 | 894 | 1.610 |
Why?
| | Cystic Fibrosis | 13 | 2026 | 1166 | 0.940 |
Why?
| | Otitis Media | 6 | 2025 | 180 | 0.880 |
Why?
| | Intestinal Mucosa | 11 | 2025 | 675 | 0.870 |
Why?
| | Feces | 17 | 2025 | 513 | 0.760 |
Why?
| | Intestines | 9 | 2017 | 357 | 0.710 |
Why?
| | Metagenome | 10 | 2019 | 149 | 0.690 |
Why?
| | Nasopharynx | 5 | 2024 | 73 | 0.640 |
Why?
| | Rhinitis | 6 | 2020 | 169 | 0.610 |
Why?
| | Biodiversity | 11 | 2020 | 425 | 0.610 |
Why?
| | Water Microbiology | 8 | 2018 | 93 | 0.600 |
Why?
| | Sinusitis | 6 | 2020 | 227 | 0.580 |
Why?
| | Paranasal Sinuses | 5 | 2016 | 81 | 0.530 |
Why?
| | Colon | 4 | 2025 | 307 | 0.490 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 141 | 0.490 |
Why?
| | Phylogeny | 13 | 2020 | 1024 | 0.490 |
Why?
| | Archaea | 2 | 2008 | 87 | 0.490 |
Why?
| | Air Microbiology | 2 | 2015 | 50 | 0.480 |
Why?
| | Ileum | 4 | 2020 | 112 | 0.460 |
Why?
| | Sequence Analysis, DNA | 14 | 2020 | 828 | 0.460 |
Why?
| | Breast Feeding | 6 | 2025 | 444 | 0.440 |
Why?
| | Bronchoalveolar Lavage Fluid | 5 | 2026 | 630 | 0.440 |
Why?
| | RNA, Bacterial | 8 | 2018 | 193 | 0.420 |
Why?
| | Sputum | 6 | 2026 | 308 | 0.410 |
Why?
| | Database Management Systems | 1 | 2013 | 50 | 0.390 |
Why?
| | Oropharynx | 3 | 2026 | 46 | 0.390 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.390 |
Why?
| | Railroads | 1 | 2013 | 6 | 0.390 |
Why?
| | User-Computer Interface | 1 | 2013 | 165 | 0.370 |
Why?
| | Aerosols | 1 | 2013 | 188 | 0.350 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 109 | 0.350 |
Why?
| | Geologic Sediments | 2 | 2008 | 47 | 0.350 |
Why?
| | Trachea | 4 | 2023 | 258 | 0.340 |
Why?
| | Colitis | 3 | 2025 | 280 | 0.340 |
Why?
| | Infant Nutritional Physiological Phenomena | 3 | 2025 | 154 | 0.320 |
Why?
| | HIV Infections | 5 | 2025 | 3148 | 0.320 |
Why?
| | Crohn Disease | 4 | 2020 | 259 | 0.320 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.310 |
Why?
| | Inflammation | 11 | 2025 | 2870 | 0.310 |
Why?
| | Humans | 82 | 2026 | 144667 | 0.300 |
Why?
| | Dysbiosis | 5 | 2023 | 187 | 0.300 |
Why?
| | DNA, Bacterial | 8 | 2021 | 347 | 0.290 |
Why?
| | Lung | 7 | 2021 | 4089 | 0.290 |
Why?
| | Genes, rRNA | 5 | 2015 | 42 | 0.280 |
Why?
| | Male | 55 | 2026 | 72431 | 0.280 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 265 | 0.270 |
Why?
| | Female | 56 | 2026 | 78304 | 0.270 |
Why?
| | Software | 1 | 2013 | 695 | 0.270 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 180 | 0.270 |
Why?
| | Case-Control Studies | 15 | 2020 | 3603 | 0.260 |
Why?
| | High-Throughput Nucleotide Sequencing | 8 | 2026 | 552 | 0.250 |
Why?
| | Sulfolobus solfataricus | 1 | 2007 | 9 | 0.250 |
Why?
| | Mice | 23 | 2025 | 18261 | 0.250 |
Why?
| | Legionella | 2 | 2017 | 9 | 0.240 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2026 | 12 | 0.240 |
Why?
| | Animals | 32 | 2025 | 37948 | 0.240 |
Why?
| | Mycobiome | 1 | 2026 | 9 | 0.240 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 229 | 0.240 |
Why?
| | Capsule Endoscopy | 1 | 2026 | 25 | 0.240 |
Why?
| | Dietary Supplements | 3 | 2019 | 575 | 0.230 |
Why?
| | HIV-1 | 2 | 2024 | 897 | 0.230 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2909 | 0.230 |
Why?
| | Fatty Liver | 2 | 2021 | 250 | 0.230 |
Why?
| | Drinking Water | 3 | 2017 | 91 | 0.230 |
Why?
| | Cryoelectron Microscopy | 1 | 2007 | 220 | 0.230 |
Why?
| | Blueberry Plants | 1 | 2025 | 8 | 0.230 |
Why?
| | Pseudomonas Infections | 3 | 2023 | 230 | 0.230 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 34 | 0.230 |
Why?
| | Fatty Acids, Volatile | 4 | 2019 | 60 | 0.230 |
Why?
| | Environmental Microbiology | 1 | 2005 | 57 | 0.220 |
Why?
| | Adult | 32 | 2026 | 40489 | 0.220 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 331 | 0.220 |
Why?
| | Drug Resistance | 2 | 2017 | 145 | 0.220 |
Why?
| | Ear, Middle | 5 | 2025 | 84 | 0.220 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.220 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 176 | 0.210 |
Why?
| | Pentanols | 1 | 2024 | 6 | 0.210 |
Why?
| | Construction Materials | 2 | 2015 | 19 | 0.210 |
Why?
| | Colitis, Ulcerative | 2 | 2020 | 148 | 0.210 |
Why?
| | Child | 23 | 2026 | 22600 | 0.210 |
Why?
| | Lyases | 1 | 2024 | 16 | 0.210 |
Why?
| | Fungi | 1 | 2026 | 161 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 100 | 0.210 |
Why?
| | Bacteremia | 2 | 2018 | 222 | 0.210 |
Why?
| | Metagenomics | 3 | 2019 | 183 | 0.210 |
Why?
| | Staphylococcus aureus | 4 | 2021 | 454 | 0.200 |
Why?
| | Ecosystem | 2 | 2007 | 591 | 0.200 |
Why?
| | Infant Formula | 2 | 2023 | 71 | 0.200 |
Why?
| | Adrenal Cortex Hormones | 3 | 2017 | 480 | 0.200 |
Why?
| | Liver | 3 | 2020 | 1889 | 0.200 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 103 | 0.200 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5967 | 0.200 |
Why?
| | Butyrates | 1 | 2024 | 66 | 0.200 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 395 | 0.200 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2017 | 3910 | 0.200 |
Why?
| | Respiratory System | 2 | 2016 | 151 | 0.190 |
Why?
| | Diet, Western | 2 | 2022 | 86 | 0.190 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 253 | 0.190 |
Why?
| | Premature Birth | 3 | 2017 | 376 | 0.190 |
Why?
| | Imaging, Three-Dimensional | 1 | 2007 | 581 | 0.190 |
Why?
| | Alternative Splicing | 1 | 2025 | 247 | 0.190 |
Why?
| | Milk, Human | 3 | 2023 | 172 | 0.190 |
Why?
| | Staphylococcus | 4 | 2017 | 75 | 0.180 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 163 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2025 | 253 | 0.180 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.180 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2018 | 365 | 0.180 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.180 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 1170 | 0.180 |
Why?
| | Iron | 2 | 2016 | 358 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 394 | 0.180 |
Why?
| | Gastrointestinal Tract | 3 | 2015 | 207 | 0.180 |
Why?
| | Infant | 12 | 2025 | 10023 | 0.170 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1928 | 0.170 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 185 | 0.170 |
Why?
| | Diet | 3 | 2025 | 1270 | 0.170 |
Why?
| | Staphylococcal Infections | 3 | 2015 | 388 | 0.170 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.170 |
Why?
| | Transcriptome | 3 | 2021 | 1036 | 0.160 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.160 |
Why?
| | Adolescent | 19 | 2026 | 22409 | 0.160 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 227 | 0.160 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 58 | 0.160 |
Why?
| | Perilipin-2 | 2 | 2017 | 40 | 0.160 |
Why?
| | Groundwater | 1 | 2020 | 41 | 0.160 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 59 | 0.160 |
Why?
| | Mucin 5AC | 1 | 2020 | 70 | 0.160 |
Why?
| | Cross-Sectional Studies | 11 | 2021 | 5870 | 0.160 |
Why?
| | Hot Springs | 2 | 2012 | 9 | 0.160 |
Why?
| | Birth Weight | 2 | 2020 | 506 | 0.160 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 15 | 0.160 |
Why?
| | Respiratory System Agents | 1 | 2020 | 22 | 0.150 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 169 | 0.150 |
Why?
| | Inflammation Mediators | 2 | 2020 | 503 | 0.150 |
Why?
| | Biofilms | 3 | 2017 | 301 | 0.150 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 141 | 0.150 |
Why?
| | Bacteroides | 1 | 2019 | 20 | 0.150 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.150 |
Why?
| | Asthma | 3 | 2017 | 1774 | 0.150 |
Why?
| | Polymerase Chain Reaction | 7 | 2017 | 1047 | 0.150 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 410 | 0.150 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4539 | 0.150 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.140 |
Why?
| | Vitamin B Complex | 1 | 2019 | 40 | 0.140 |
Why?
| | Chronic Disease | 7 | 2022 | 1810 | 0.140 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 178 | 0.140 |
Why?
| | Middle Aged | 21 | 2024 | 35971 | 0.140 |
Why?
| | Oxonic Acid | 1 | 2018 | 13 | 0.140 |
Why?
| | Diet, High-Fat | 2 | 2017 | 261 | 0.140 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2350 | 0.140 |
Why?
| | Biomarkers | 6 | 2025 | 4261 | 0.140 |
Why?
| | Child, Preschool | 10 | 2026 | 11790 | 0.140 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 9 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 47 | 0.140 |
Why?
| | Vitamin B 12 | 1 | 2019 | 127 | 0.140 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 16 | 0.140 |
Why?
| | Body Mass Index | 4 | 2020 | 2419 | 0.140 |
Why?
| | Corrosion | 2 | 2015 | 16 | 0.140 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 16 | 0.140 |
Why?
| | Burns | 1 | 2023 | 371 | 0.140 |
Why?
| | Chloramines | 2 | 2015 | 14 | 0.140 |
Why?
| | Probiotics | 1 | 2018 | 61 | 0.130 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 323 | 0.130 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.130 |
Why?
| | Immunity, Innate | 3 | 2019 | 843 | 0.130 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 13 | 0.130 |
Why?
| | Quinolones | 1 | 2020 | 202 | 0.130 |
Why?
| | Aminophenols | 1 | 2020 | 202 | 0.130 |
Why?
| | Infant, Newborn | 8 | 2025 | 6399 | 0.130 |
Why?
| | Sequence Analysis, RNA | 3 | 2020 | 442 | 0.130 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Clostridium Infections | 1 | 2018 | 74 | 0.120 |
Why?
| | Sepsis | 1 | 2023 | 643 | 0.120 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 562 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 303 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.120 |
Why?
| | Down Syndrome | 1 | 2023 | 522 | 0.120 |
Why?
| | Pharynx | 1 | 2016 | 59 | 0.120 |
Why?
| | Pedigree | 3 | 2025 | 515 | 0.120 |
Why?
| | Vitamin E | 1 | 2016 | 123 | 0.120 |
Why?
| | Rivers | 1 | 2016 | 68 | 0.120 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 19 | 0.120 |
Why?
| | Lipid Metabolism | 2 | 2020 | 524 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 6 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 68 | 0.120 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 62 | 0.120 |
Why?
| | Respiration, Artificial | 3 | 2023 | 710 | 0.110 |
Why?
| | Cytokines | 3 | 2025 | 2045 | 0.110 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.110 |
Why?
| | Young Adult | 11 | 2021 | 14122 | 0.110 |
Why?
| | Base Sequence | 3 | 2015 | 2177 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2025 | 3109 | 0.110 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.110 |
Why?
| | Lactobacillus | 3 | 2022 | 28 | 0.110 |
Why?
| | Dietary Fats | 1 | 2017 | 308 | 0.110 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 161 | 0.110 |
Why?
| | Sanitary Engineering | 1 | 2015 | 6 | 0.110 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 59 | 0.110 |
Why?
| | Nose | 1 | 2015 | 68 | 0.110 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.110 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 40 | 0.110 |
Why?
| | Biota | 1 | 2015 | 35 | 0.110 |
Why?
| | Bronchi | 1 | 2016 | 263 | 0.110 |
Why?
| | Health Facilities | 1 | 2015 | 86 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 195 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 28 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 52 | 0.110 |
Why?
| | Prospective Studies | 7 | 2022 | 7994 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 247 | 0.110 |
Why?
| | Rats | 6 | 2023 | 5570 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 129 | 0.100 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 134 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 641 | 0.100 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2014 | 62 | 0.100 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 657 | 0.100 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 30 | 0.100 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 48 | 0.100 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 49 | 0.100 |
Why?
| | Cecum | 3 | 2020 | 37 | 0.100 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 101 | 0.100 |
Why?
| | Age Factors | 2 | 2019 | 3329 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 985 | 0.100 |
Why?
| | DNA, Ribosomal | 2 | 2015 | 97 | 0.100 |
Why?
| | Nasal Cavity | 1 | 2013 | 62 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 21 | 0.100 |
Why?
| | Cities | 1 | 2013 | 143 | 0.100 |
Why?
| | Autoantibodies | 2 | 2018 | 1505 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 218 | 0.100 |
Why?
| | New York City | 1 | 2013 | 89 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 67 | 0.100 |
Why?
| | Saliva | 1 | 2015 | 247 | 0.100 |
Why?
| | Computational Biology | 2 | 2019 | 681 | 0.100 |
Why?
| | Iron, Dietary | 1 | 2013 | 23 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 849 | 0.090 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 117 | 0.090 |
Why?
| | Hippocampus | 1 | 2018 | 966 | 0.090 |
Why?
| | Membrane Proteins | 2 | 2019 | 1159 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 339 | 0.090 |
Why?
| | Antioxidants | 1 | 2016 | 546 | 0.090 |
Why?
| | Gastric Bypass | 1 | 2014 | 126 | 0.090 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 236 | 0.090 |
Why?
| | Prednisone | 1 | 2013 | 221 | 0.090 |
Why?
| | Pediatric Obesity | 1 | 2020 | 637 | 0.090 |
Why?
| | Aged | 11 | 2023 | 25955 | 0.090 |
Why?
| | Infant Food | 1 | 2013 | 64 | 0.090 |
Why?
| | Seawater | 1 | 2012 | 34 | 0.090 |
Why?
| | Bacterial Infections | 1 | 2014 | 247 | 0.090 |
Why?
| | Carbon Dioxide | 1 | 2014 | 239 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 242 | 0.090 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 248 | 0.090 |
Why?
| | Paneth Cells | 1 | 2012 | 20 | 0.090 |
Why?
| | Xenobiotics | 1 | 2012 | 31 | 0.090 |
Why?
| | Mexico | 2 | 2012 | 234 | 0.090 |
Why?
| | Pregnancy | 6 | 2025 | 7122 | 0.090 |
Why?
| | Body Fluids | 1 | 2012 | 71 | 0.090 |
Why?
| | Bacterial Translocation | 1 | 2012 | 52 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 143 | 0.090 |
Why?
| | Islets of Langerhans | 2 | 2015 | 842 | 0.090 |
Why?
| | Sequence Analysis | 1 | 2011 | 35 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1495 | 0.080 |
Why?
| | Autoimmunity | 2 | 2015 | 930 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2014 | 288 | 0.080 |
Why?
| | Esophagus | 1 | 2012 | 262 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2018 | 1148 | 0.080 |
Why?
| | Autism Spectrum Disorder | 1 | 2015 | 410 | 0.080 |
Why?
| | Phenotype | 5 | 2020 | 3147 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 423 | 0.080 |
Why?
| | Genes, Bacterial | 3 | 2018 | 170 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 93 | 0.080 |
Why?
| | Obesity | 2 | 2021 | 3070 | 0.080 |
Why?
| | Genotype | 4 | 2019 | 1847 | 0.070 |
Why?
| | Cholesterol | 2 | 2022 | 404 | 0.070 |
Why?
| | Pacific Ocean | 1 | 2008 | 8 | 0.070 |
Why?
| | RNA, Archaeal | 1 | 2008 | 13 | 0.070 |
Why?
| | Cohort Studies | 5 | 2019 | 5957 | 0.070 |
Why?
| | DNA, Archaeal | 1 | 2008 | 18 | 0.070 |
Why?
| | Indoles | 1 | 2013 | 504 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 156 | 0.070 |
Why?
| | Pseudomonas aeruginosa | 2 | 2023 | 391 | 0.070 |
Why?
| | Weight Loss | 1 | 2014 | 839 | 0.070 |
Why?
| | Exome | 2 | 2020 | 227 | 0.070 |
Why?
| | Smoke | 2 | 2023 | 147 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2573 | 0.070 |
Why?
| | Methane | 2 | 2020 | 51 | 0.070 |
Why?
| | Bacterial Load | 2 | 2021 | 67 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2013 | 776 | 0.060 |
Why?
| | Cryoprotective Agents | 1 | 2007 | 11 | 0.060 |
Why?
| | Fatty Acids | 2 | 2022 | 454 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 919 | 0.060 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2007 | 62 | 0.060 |
Why?
| | Models, Statistical | 1 | 2011 | 677 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2025 | 2033 | 0.060 |
Why?
| | Freezing | 1 | 2007 | 86 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 973 | 0.060 |
Why?
| | Gammaproteobacteria | 2 | 2016 | 13 | 0.060 |
Why?
| | Equipment Contamination | 2 | 2017 | 71 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2010 | 733 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2020 | 342 | 0.060 |
Why?
| | Genes, Archaeal | 1 | 2005 | 6 | 0.060 |
Why?
| | Cryopreservation | 1 | 2007 | 106 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 195 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2017 | 104 | 0.060 |
Why?
| | Insulin | 1 | 2016 | 2502 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 1076 | 0.050 |
Why?
| | Body Composition | 2 | 2021 | 689 | 0.050 |
Why?
| | Hexanols | 1 | 2024 | 7 | 0.050 |
Why?
| | Fruit | 1 | 2025 | 148 | 0.050 |
Why?
| | Water Purification | 2 | 2017 | 157 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2591 | 0.050 |
Why?
| | Methylamines | 1 | 2024 | 40 | 0.050 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 187 | 0.050 |
Why?
| | Disinfection | 2 | 2017 | 131 | 0.050 |
Why?
| | Treatment Outcome | 5 | 2020 | 11735 | 0.050 |
Why?
| | Gestational Age | 2 | 2017 | 980 | 0.050 |
Why?
| | Tobramycin | 1 | 2023 | 59 | 0.050 |
Why?
| | Administration, Oral | 2 | 2019 | 851 | 0.050 |
Why?
| | Choline | 1 | 2024 | 136 | 0.050 |
Why?
| | Geography | 2 | 2014 | 203 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2018 | 2815 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1537 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 562 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 118 | 0.050 |
Why?
| | Colorado | 3 | 2020 | 4558 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 8284 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Azithromycin | 1 | 2023 | 105 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 65 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 845 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 56 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 76 | 0.050 |
Why?
| | Neutrophils | 2 | 2021 | 1118 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 218 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 175 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 9 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2873 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2017 | 1154 | 0.040 |
Why?
| | Water | 2 | 2018 | 468 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2023 | 570 | 0.040 |
Why?
| | Virulence | 1 | 2023 | 282 | 0.040 |
Why?
| | Brain | 1 | 2014 | 2934 | 0.040 |
Why?
| | Gastritis | 1 | 2022 | 116 | 0.040 |
Why?
| | Multigene Family | 2 | 2012 | 210 | 0.040 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 60 | 0.040 |
Why?
| | Enteritis | 1 | 2022 | 104 | 0.040 |
Why?
| | Endoscopy | 2 | 2015 | 317 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 662 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 450 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2942 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 21 | 0.040 |
Why?
| | Smoking | 2 | 2020 | 1467 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2117 | 0.040 |
Why?
| | Mice, Inbred NOD | 2 | 2013 | 610 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 779 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 33 | 0.040 |
Why?
| | Ear, External | 1 | 2020 | 21 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 222 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 231 | 0.040 |
Why?
| | Hospitals | 2 | 2015 | 729 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 99 | 0.040 |
Why?
| | Cell Line | 2 | 2018 | 2821 | 0.040 |
Why?
| | Bacterial Proteins | 2 | 2018 | 981 | 0.040 |
Why?
| | Mouth | 1 | 2020 | 88 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 547 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2022 | 227 | 0.040 |
Why?
| | Sweat | 1 | 2020 | 51 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 112 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 360 | 0.040 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 143 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 75 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 448 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 55 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 177 | 0.030 |
Why?
| | Collagen Type II | 1 | 2018 | 54 | 0.030 |
Why?
| | HIV Seropositivity | 1 | 2019 | 119 | 0.030 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 110 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 366 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2020 | 374 | 0.030 |
Why?
| | Risk Factors | 3 | 2017 | 10796 | 0.030 |
Why?
| | New Orleans | 1 | 2017 | 15 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 98 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2018 | 109 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 74 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 166 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2017 | 49 | 0.030 |
Why?
| | Prognosis | 2 | 2020 | 4312 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 449 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 475 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 68 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2017 | 200 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1251 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 94 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 7 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 70 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 90 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 639 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 187 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 888 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 28 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 145 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 613 | 0.030 |
Why?
| | Bacillus | 1 | 2015 | 17 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 743 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 371 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 133 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 203 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3888 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 998 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 183 | 0.030 |
Why?
| | Pseudomonas | 1 | 2015 | 33 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 40 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 127 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 138 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 79 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 44 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 21 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 510 | 0.030 |
Why?
| | Proteobacteria | 1 | 2014 | 16 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1447 | 0.030 |
Why?
| | Physical Exertion | 1 | 2015 | 205 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 49 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 915 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 34 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 88 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 42 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 52 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 169 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 123 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 201 | 0.030 |
Why?
| | Spirometry | 1 | 2015 | 231 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 95 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 501 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2019 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 58 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2012 | 2137 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 516 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1476 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 37 | 0.020 |
Why?
| | Cell Separation | 1 | 2014 | 303 | 0.020 |
Why?
| | Observer Variation | 1 | 2014 | 355 | 0.020 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 151 | 0.020 |
Why?
| | Connectome | 1 | 2014 | 93 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 396 | 0.020 |
Why?
| | Nitrates | 1 | 2013 | 100 | 0.020 |
Why?
| | Perioperative Care | 1 | 2015 | 231 | 0.020 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.020 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.020 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.020 |
Why?
| | Seasons | 1 | 2015 | 556 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 332 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 43 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 320 | 0.020 |
Why?
| | DNA, Viral | 1 | 2014 | 357 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 287 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1886 | 0.020 |
Why?
| | Neural Pathways | 1 | 2014 | 311 | 0.020 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Alprostadil | 1 | 2012 | 29 | 0.020 |
Why?
| | Phototrophic Processes | 1 | 2012 | 1 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 614 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1938 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 53 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 54 | 0.020 |
Why?
| | Hot Temperature | 1 | 2015 | 410 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 330 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 62 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 104 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2922 | 0.020 |
Why?
| | Cyanobacteria | 1 | 2012 | 54 | 0.020 |
Why?
| | Suction | 1 | 2011 | 32 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1338 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 109 | 0.020 |
Why?
| | Skin | 1 | 2016 | 762 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 477 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 158 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 541 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 393 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 968 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 1106 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 247 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 527 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 368 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5414 | 0.020 |
Why?
| | Adiposity | 1 | 2015 | 529 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2326 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.020 |
Why?
| | Nutritional Status | 1 | 2013 | 351 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 751 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2012 | 207 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 531 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2847 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 477 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4110 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 319 | 0.020 |
Why?
| | Risk | 1 | 2011 | 911 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1079 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 4081 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1766 | 0.020 |
Why?
| | Thermus | 1 | 2007 | 1 | 0.020 |
Why?
| | Chloroflexi | 1 | 2007 | 12 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 854 | 0.020 |
Why?
| | Mining | 1 | 2007 | 37 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1496 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1419 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 989 | 0.010 |
Why?
| | Hospitalization | 1 | 2015 | 2446 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 680 | 0.010 |
Why?
| | United States | 1 | 2015 | 16018 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 17149 | 0.010 |
Why?
|
|
Robertson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|